Emma Yapp summarises two new studies out yesterday looking at the PATH intervention (Psychological Advocacy Towards Healing), a CBT-informed psychological intervention delivered by trained domestic violence and abuse (DVA) advocates in specialist services.
[read the full story...]
In the lead up to our Loneliness Mental Health Question Time on 3rd Dec 2018, Dr Michelle Lim summarises a recent systematic review on the associations between loneliness and perceived social support and outcomes of mental health problems.
[read the full story...]
A group of UCL Mental Health Masters students summarise a recent network meta-analysis that highlights a lack of evidence about specific interventions for preventing psychosis.
[read the full story...]
Andy Bell from Centre for Mental Health and the Equally Well UK collaborative, calls for action in response to the Public Health England briefing on severe mental illness and physical health inequalities.
[read the full story...]
Vishal Bhavsar reviews an EU study of nearly 3,000 people across 6 EU countries, looking at the treated incidence of schizophrenia and psychotic disorders. It helps us better understand who gets psychosis, when, and where.
[read the full story...]
Suzi Gage summarises a recent GWAS of lifetime cannabis use, which reveals new risk loci, genetic overlap with psychiatric traits, and a causal influence of schizophrenia. Interesting new evidence ahead of our Mental Health Question Time #MHQT event in London tomorrow.
[read the full story...]
Jingyi Wang publishes her debut blog on a recent systematic review of loneliness in psychosis, which shows that the relationship between loneliness and psychosis remains poorly understood due to a lack of high quality studies.
[read the full story...]
Luke Sheridan Rains publishes his debut blog on a recent multicentre RCT of Cannabidiol (CBD) as an adjunctive therapy for people with schizophrenia, which suggests that CBD had a beneficial, but modest impact on positive psychotic symptoms and severity of illness when used alongside existing antipsychotics.
[read the full story...]
Elwira Lubos summarises the recent ATLAS RCT of antipsychotic treatment for very late-onset schizophrenia-like psychosis, which provides evidence for the effectiveness of a very low dose of Amisulpride (100 mg).
[read the full story...]
Ian Hamilton explores a recent Finnish study of adolescent tobacco smoking and the risk of psychosis, which found that young people aged 15-16 who smoked more than 10 cigarettes a day were three times more likely to have psychosis by the time they reached age 30.
[read the full story...]
